Results 231 to 240 of about 174,092 (264)

Cord blood T-Cell imbalances as early predictors of bronchopulmonary dysplasia in extremely preterm neonates. [PDF]

Respir Res
Li Y, Xue Y, Zhang L, Xu Y, Guo X, Zhang X, Li H, Yang Y, Wang Y, Zhu X, Wang H, Jing X, Zhu C, Xu F.   +13 more
europepmc   +1 more source

A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy

BMEMat, EarlyView.
ZIF‐8‐based nanoparticles co‐delivering CB‐839 (glutaminase inhibitor) and 1‐MT (IDO1 inhibitor), dual‐targeting glutamine/tryptophan metabolism to induce immunogenic cell death, activate STING, block kynurenine production, reverse immunosuppression, and enhance cancer immunotherapy to suppress primary/distant tumors.
Wenli Ning, Yunhan Sun, Mingyang Li, Shilu Liu, Fangjie Yi, Hongfei Wang, Ruibing Bai, Dongdong Liu, Fen Zhao, Guiqiang Zhang, Xiao Fu   +10 more
wiley   +1 more source

Regulatory T-cell remodeling across the HBV infection-cirrhosis continuum. [PDF]

Front Immunol
Fu Y, Wang Y, Ouyang J, Lv W.
europepmc   +1 more source

Rezpegaldesleukin and Regulatory T Cell Restoration in Immune-Mediated Skin Diseases. [PDF]

Dermatol Ther (Heidelb)
Domingues J, Chovatiya R, King B, Torres T.   +3 more
europepmc   +1 more source

Targeting FOXP3 and Regulatory T Cells in Systemic Lupus Erythematosus: Emerging Therapeutic Strategies and Clinical Prospects. [PDF]

J Cell Biochem
Du S, Xu W, Zhao L, Shi X, Liu R.
europepmc   +1 more source

Research Progress of Molecular H₂ in Mediating Immune Tolerance via Regulating Tregs-from the Perspective of the 2025 Nobel Prize in Physiology or Medicine. [PDF]

Drug Des Devel Ther
Ding X, Tang W, Wang Y, Tian J, Shi J, Wei Y, Cui C.   +6 more
europepmc   +1 more source